Skip to main content
. 2019 Mar 28;62(1):14–23. doi: 10.33160/yam.2019.03.003

Table 4.

Parameters before and after intervention (subgroup with an increase of bowel movements after fucoidan)

Parameter n Fucoidan intake n Placebo intake
Before After Before After
Clinical Body weight (kg) 11 65.44 ± 7.48 64.76 ± 8.04 11 65.64 ± 7.52 65.28 ± 7.89
BMI (kg/m2) 11 24.95 ± 2.71 24.69 ± 2.81 11 25.03 ± 2.76 25.02 ± 2.79
Body fat (%) 9 28.24 ± 6.23 27.90 ± 6.43 11 28.78 ± 7.97 29.41 ± 7.36
Waist circumference (cm) 10 86.12 ± 5.97 87.28 ± 6.64 11 87.16 ± 5.76 86.00 ± 7.49
Systolic blood pressure (mmHg) 9 135.22 ± 17.06 135.22 ± 16.97 5 147.00 ± 22.55 141.40 ± 19.27
Diastolic blood pressure (mmHg) 9 80.33 ± 16.78 75.67 ± 14.35 5 77.80 ± 8.90 72.60 ± 13.45
Biochemical FPG (mmol/L) 11 8.10 ± 2.05 7.83 ± 1.83 11 7.55 ± 2.00 7.99 ± 2.16
HbA1c (%) 11 7.58 ± 1.08 7.38 ± 1.00 11 7.36 ± 1.07 7.35 ± 1.20
Insulin (pmol/mL) 11 43.20 ± 39.00 46.20 ± 26.40 11 45.00 ± 39.00 43.80 ± 25.20
HOMA-IR 11 2.49 ± 1.90 2.62 ± 1.39 11 2.55 ± 2.16 2.61 ± 1.58
Leptin (nmol/L) 11 0.36 ± 0.30* 0.51 ± 0.43* 11 0.40 ± 0.33 0.47 ± 0.39
HMW-adiponectin (μmol/L) 11 0.23 ± 0.21 0.19 ± 0.19 11 0.21 ± 0.21 0.22 ± 0.23
GLP-1 (pmol/L) 11 5.70 ± 1.76* 4.76 ± 2.22* 11 5.33 ± 1.75 5.12 ± 2.59
LDL-C (mmol/L) 9 3.15 ± 0.85 3.10 ± 0.65 10 2.95 ± 0.80 3.13 ± 0.80
HDL-C (mmol/L) 9 1.59 ± 0.75 1.57 ± 0.62 10 1.51 ± 0.59 1.57 ± 0.62
Triglyceride (mmol/L) 9 1.76 ± 1.41 1.63 ± 1.41 10 1.80 ± 1.80 1.68 ± 1.05
T-cholesterol (mmol/L) 6 5.51 ± 1.19 5.38 ± 0.80 4 4.73 ± 0.49 5.04 ± 0.75
AST (U/L) 3 22.67 ± 12.50 27.33 ± 15.37 5 22.60 ± 9.13 23.60 ± 4.72
ALT (U/L) 3 32.33 ± 18.77 36.33 ± 22.23 5 26.20 ± 16.00 26.80 ± 7.52
γ-GTP (U/L) 3 42.00 ± 18.33 38.67 ± 20.43 5 34.40 ± 18.88 33.60 ± 14.28
Zinc (mmol/L) 11 12.45 ± 0.87 12.01 ± 1.42 11 12.96 ± 1.47 12.59 ± 1.70

Data are the mean ± SD; *: P < 0.05.

AST, aspartate transaminase; ALT, alanine aminotransferase; BMI, body mass index; FPG, fasting plasma glucose; γ-GTP, γ-glutamyl transpeptidase; GLP-1, glucagon-like peptide-1; HbA1c, hemoglobin A1c; HDL-C, high density lipoprotein-cholesterol; HMW, high molecular weight; HOMA-IR, homeostatic model assessment of insulin resistance; LDL-C, low density lipoprotein-cholesterol; T-cholesterol, total cholesterol.